For the Inventor, By the Inventor

Enter assignee name

Piscataway, NJ, United States of America

Kashiv Biosciences, LLC

USPTO Granted Patents = 20

CIPO Patents = 1

Trademarks = 8

Forward Citations = 27

Loading Chart...

Loading Chart...

26 inventors (with patents filed for the assignee):

Dipen Desai (13 out of 50 patents)

Wantanee Phuapradit (13 out of 57 patents)

Navnit Hargovindas Shah (13 out of 74 patents)

4. Siva Ram Kiran Vaka (8 out of 31 patents)

5. Kanji Meghpara (5 out of 15 patents)

6. Jaydeep Vaghashiya (4 out of 20 patents)

7. Namdev B Shelke (4 out of 20 patents)

8. Atsawin Thongsukmak (4 out of 12 patents)

9. Mayankkumar Thakkar (3 out of 3 patents)

10. Tarun Kumar Gupta (3 out of 3 patents)

11. Om Narayan (3 out of 3 patents)

12. Harpreet Kaur Sandhu (2 out of 18 patents)

13. Ashish Chatterji (2 out of 9 patents)

14. Parva Yogeshchandra Purohit (2 out of 3 patents)

15. Paras Rasiklal Vasanani (2 out of 3 patents)

20 patents: Sort by Forward Citations

1. 12440534 - Stable ready to dilute composition of carfilzomib (2025-10-14),

2. 12435106 - Process of purification of protein (2025-10-07),

3. 12378282 - Process of purification of protein (2025-08-05),

4. 12352759 - Assay method of antibody (2025-07-08),

5. 12139510 - Process of purification of protein (2024-11-12),

6. 11760741 - Pro-drugs of eliglustat (2023-09-19),

7. 11285152 - Stable oral pharmaceutical composition of imatinib (2022-03-29),

8. 10960001 - Opioid agonist / antagonist combination dosage forms (2021-03-30),

9. 10898431 - Programmable pharmaceutical compositions for chrono drug release (2021-01-26),

10. 10898430 - Self-regulating osmotic gastroretentive drug delivery systems (2021-01-26),

11. 10881617 - Extended release compositions comprising pyridostigmine (2021-01-05),

12. 10869839 - Extended release compositions comprising trihexyphenidyl (2020-12-22),

13. 10849846 - Self-regulating osmotic gastroretentive drug delivery systems (2020-12-01),

14. 10744131 - Abuse-resistant drug formulations (2020-08-18),

15. 10744093 - Extended release compositions comprising pyridostigmine (2020-08-18),

Kashiv Biosciences, LLC is a leading pharmaceutical company focused on developing novel drug products to improve patient outcomes. With a wide range of capabilities spanning research and development, manufacturing, and commercialization, Kashiv strives to bring innovative therapies to market efficiently. Their expertise lies in developing complex generic and 505(b)(2) drug products across various therapeutic areas, ensuring high quality and affordability for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

20 Patents

#10 in Piscataway, NJ

#624 in New Jersey

#15,886 in US

#30,351 in the World

Piscataway, NJ, United States of America

Kashiv Biosciences, LLC

Forward Citations = 27

26 inventors:

Dipen Desai (13 out of 50 patents)

Wantanee Phuapradit (13 out of 57 patents)

Navnit Hargovindas Shah (13 out of 74 patents)

4. Siva Ram Kiran Vaka (8 out of 31 patents)

5. Kanji Meghpara (5 out of 15 patents)

Please report any incorrect information to support@idiyas.com

Loading…